Adding Chemo Boosts Prostate Cancer SurvivalAdding Chemo Boosts Prostate Cancer Survival
A federally funded phase 3 clinical trial provides more evidence supporting the addition of docetaxel chemotherapy to standard hormone and radiation treatment in men with high-risk disease. Medscape News Slideshows
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Docetaxel | Health | Hematology | Hormones | Prostate Cancer | Taxotere